RxDoctor Payments Data

William Roberts, MD

Anesthesiology · Newburgh, INNPI 1336138650

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 40.3% of the total. Among anesthesiology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,239in general payments, 2019–2025

Across 172 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Medtronic$366
  • Amgen$213
  • Si-bone, Inc.$158
  • Nevro Corp.$157
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$152
  • plus $888 from 25 others

What the payments were for

  • Food & beverage$3,239100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,239 in reported general payments places this provider in the 95th percentile of 1,203 anesthesiology providers in Indiana.

See all anesthesiology providers in Indiana

Medicare billing

Part B allowed, 2024
$97,310
Medicare patients
355
Services billed
962

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant20$17,160
OxycontinOxycodone Hcl14$7,454
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen245$5,679
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen152$4,304
Gabapentin78$1,910
AmantadineAmantadine Hcl13$1,748
Morphine Sulfate ErMorphine Sulfate52$1,678
Oxycodone Hcl54$1,115
Pregabalin25$617
Tramadol Hcl29$373
Morphine Sulfate15$367
Tizanidine Hcl24$352
Cyclobenzaprine Hcl20$352
Duloxetine Hcl18$270
Methadone Hcl15$195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy$1,304$17,16020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,203 anesthesiology providers in Indiana.

Other anesthesiology in Newburgh

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →